Bacillus subtilis var. natto bacteremia: A case series and review
Abstract
Natto, a traditional Japanese fermented soybean food, contains Bacillus subtilis var. natto, which is generally regarded as safe but can rarely cause bloodstream infections in susceptible individuals. We report three cases of B. subtilis var. natto bacteremia confirmed by biotin operon analysis: a 63-year-old man receiving maintenance hemodialysis, a 35-year-old woman at 36 weeks of gestation, and a 62-year-old man whose bacteremia led to the diagnosis of colorectal cancer. All patients reported habitual natto consumption and had underlying conditions associated with impaired intestinal barrier function or altered immune status. Blood cultures yielded Bacillus subtilis, which was initially regarded as a contaminant. Targeted antimicrobial therapy resulted in resolution of bacteremia in all patients; the pregnant patient underwent emergency cesarean delivery, and the third patient subsequently underwent surgical resection for colorectal cancer. When considered together with previously published cases, our findings suggest that B. subtilis var. natto bacteremia primarily occurs in patients with impaired host defenses or intestinal barrier dysfunction. Biotin operon analysis identified characteristic genetic features of B. subtilis var. natto, consistent with a likely dietary origin associated with natto consumption. Because Bacillus species isolated from blood cultures are often dismissed as contaminants, B. subtilis var. natto bacteremia is likely underrecognized. Clinicians…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.